When examining bone marrow samples from breast cancer patients, cells that showed a positive nuclear staining with DAPI and a positive staining against Pan-CK, ER, HER2, or multiple markers at once were captured and considered as tumor cells. Here, ERBB2 is linked to breast carcinoma.